Viewing Study NCT00081302


Ignite Creation Date: 2025-12-25 @ 4:03 AM
Ignite Modification Date: 2025-12-26 @ 2:57 AM
Study NCT ID: NCT00081302
Status: COMPLETED
Last Update Posted: 2015-11-17
First Post: 2004-04-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer
Sponsor: Radiation Therapy Oncology Group
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: RTOG-0324
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View